Prelude Capital Management, LLC Axsome Therapeutics, Inc. Put Options Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $170,640 - $298,008	-7,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $221,040 - $312,192	7,200 New	7,200 $272,000
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $34,909 - $69,083	-700 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $12,360 - $30,393	300 Added 75.0%	700 $41,000
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $6,684 - $42,496	400 New	400 $41,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.